Special drug use survey of DARZQURO Combination Subcutaneous Injection (Multiple Myeloma)
Not Applicable
- Conditions
- Multiple Myeloma
- Registration Number
- JPRN-UMIN000044074
- Lead Sponsor
- Janssen Pharmaceutical K.K.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with a history of the use of Daratumumab.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety(Adverse Drug Reaction)
- Secondary Outcome Measures
Name Time Method